Previous Article | Next Article 
Journal of Virology, September 2001, p. 8137-8146, Vol. 75, No. 17
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.17.8137-8146.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Simian Immunodeficiency Virus in Which nef and U3
Sequences Do Not Overlap Replicates Efficiently In Vitro and In
Vivo in Rhesus Macaques
Jan
Münch,1,
Nadia
Adam,1
Nathaly
Finze,1
Nicole
Stolte,2
Christiane
Stahl-Hennig,2
Dietmar
Fuchs,3
Peter
Ten
Haaft,4
Jonathan L.
Heeney,4 and
Frank
Kirchhoff1,*
Institute for Clinical and Molecular Virology, University
of Erlangen-Nürnberg, 91054 Erlangen,1 and
German Primate Center, 37077 Göttingen,2 Germany; Institute of
Medical Chemistry and Biochemistry, University of Innsbruck, and
Ludwig Bolzmann Institute of AIDS Research, A-6020 Innsbruck,
Austria3; and Department of
Virology, Biomedical Primate Research Center, 2288 GJ Rijswijk, The
Netherlands4
Received 26 March 2001/Accepted 21 May 2001
 |
ABSTRACT |
The nef genes of human immunodeficiency virus and
simian immunodeficiency virus (SIV) overlap about 80% of the U3 region
of the 3' long terminal repeat (LTR) and contain several essential cis-acting elements (here referred to as the TPI
region): a T-rich region, the polypurine tract, and attachment
(att) sequences required for integration. We inactivated
the TPI region in the nef reading frame of the
pathogenic SIVmac239 clone (239wt) by 13 silent point mutations. To
restore viral infectivity, intact cis-regulatory elements were inserted just downstream of the mutated
nef gene. The resulting SIV genome contains U3 regions
that are 384 bp shorter than the 517-bp 239wt U3 region. Overall,
elimination of the duplicated Nef coding sequences truncates the
proviral genome by 350 bp. Nonetheless, it contains all known coding
sequences and cis-acting elements. The TPI mutant virus
expressed functional Nef and replicated like 239wt in all cell culture
assays and in vivo in rhesus macaques. Notably, these SIVmac constructs
allow us to study Nef function in the context of replication-competent
viruses without the restrictions of overlapping LTR sequences and
important cis-acting elements. The genomes of all known
primate lentiviruses contain a large overlap between nef
and the U3 region. We demonstrate that this conserved genomic
organization is not obligatory for efficient viral replication and pathogenicity.
 |
INTRODUCTION |
The nef gene is
characteristic of primate lentiviruses and important for the full
pathogenic potential of both human immunodeficiency virus (HIV) and
simian immunodeficiency virus (SIV) (11, 24, 27). A number
of Nef functions that might increase virulence and allow the
maintenance of high virus burdens have been described (reviewed in
references 14 and 32). Nef downmodulates
class I MHC and CD4 cell surface expression (3, 9, 15, 30, 35). Furthermore, Nef increases the infectivity of viral
particles and stimulates viral replication in primary peripheral blood
mononuclear cells, macrophages, and tonsillar histocultures (1,
8, 12, 16, 28, 31, 36). Recent studies suggest that most or all of these Nef activities are functionally independent and contribute to
efficient viral replication and persistence in vivo (4, 6, 19,
20, 29, 37).
The use of replication-competent primate lentiviruses is obligatory to
assess the effect of specific alterations in Nef on viral replication
and pathogenicity. Also, the effects of Nef on cell surface expression
of class I MHC and CD4 molecules and on signal transduction pathways
are ideally investigated in infected cells. However, a detailed
structure-function analysis is complicated because the nef
open reading frame (ORF) overlaps several cis-acting elements and the U3 region in the viral long terminal repeat (LTR). A
T-rich sequence (22), the polypurine tract (PPT), and the viral attachment (att) site at the 5' end of the U3 region
are essential for lentiviral replication (reviewed in reference
39). Mutations in the corresponding Nef region cannot be
made without changing these critical cis-acting elements.
Furthermore, the entire 3' half of the nef gene overlaps the
U3 region of the LTR. Therefore, after reverse transcription (RT),
changes in the C-terminal half of Nef might have unexpected effects on
transcriptional 5' LTR activity, which could affect the results of
replication and infectivity assays.
Previous findings suggest that 332 to 407 bp of U3 sequences upstream
of the major core enhancer and promoter elements (US sequences)
serve mainly as a nef coding sequence (21, 26, 27,
33). After infection of rhesus macaques with an SIVmac239 variant containing deletions in the nef unique region,
additional deletions accumulate over time in the US region
(26). Similar U3 deletions were selected in a long-term
survivor of HIV-1 infection in whom only nef-deleted
proviral sequences could be detected (27). Furthermore, an
SIV variant containing a large number of nucleotide changes in the US
region which did not affect the predicted nef coding
sequence showed normal pathogenic potential in infected rhesus macaques
(21). These SIVmac and HIV-1 variants did not contain most
of the wild-type upstream U3 sequences. However, they were either
attenuated, because of a deleted nef ORF (26, 27), or they maintained the nef-LTR overlap and the
wild-type length of the U3 region as well as the essential
cis-regulatory elements in the nef gene
(21).
These previous studies showed that large parts of the US region serve
mainly as nef coding sequence and do not contain important transcriptional elements. Therefore, it is unclear why the U3 regions
of HIV and SIV are considerably longer than those of other lentiviruses
(about 450 to 560 bp in length) and why they overlap the nef
ORF by about 70%. To address these questions, we mutated the
cis-acting elements in the SIVmac239 nef gene and
introduced an intact TPI element downstream of the mutated
nef ORF. The TPI region was either inserted just 14 bp
upstream of the 5' end of the single NF-
B site or 50 bp further
upstream, because previous studies suggested that this US region might
contain important enhancer elements (21, 26, 27, 33).
These modifications had several consequences: (i) the nef
gene of these proviral constructs does not overlap the LTR region; (ii)
the nef ORF does not contain essential cis-acting
elements; and (iii) these SIVmac variants possess short U3-LTR
sequences. We found that SIVmac does not require long U3 regions for
efficient replication in vitro and in vivo in rhesus macaques.
Furthermore, we established a system to study nef function
using infectious viruses without the limitations of overlapping
cis-regulatory and LTR elements.
 |
MATERIALS AND METHODS |
Mutant construction.
Site-directed mutagenesis to generate
the SIVmac239 TPI variants was performed by spliced overlap extension
PCR as described previously (28). Briefly, the
env-nef region of SIVmac239 (23, 34) was
amplified using primer pNheI (5'-GTACAAATGCTAGCTAAG-3') and
pPPT5
(5'-CTAAACCACCTTTCTCCTTAATGAAGTGAGACATGTCTATTGC-3'). The nef-LTR region was amplified using primer pPPT3
(5'-AAGGAGAAAGGTGGTTTAGAGGGTATCTATTACAGTGCAAGAAG-3') and p3nefSmaI (5'-TCCCCCCGGGGGAAAGTCCCTGCTGTT-3'). Mutated
positions are underlined. The left- and right-half PCR products were
gel purified, mixed in equimolar amounts, and subjected to a second PCR
with primers pNhe1 and p3nefSmaI. To generate 239nefMTPI
5, the PCR
product was cloned into the SIVmac 239
US384 construct (33) by using the unique NheI and
SmaI sites in the env gene and just upstream of
the TPI region. An overview of the mutants analyzed is given in Fig.
1 and 2. To
generate 239TPImut, the TPI region of wild-type SIVmac239 was replaced
with the mutated sequence using the flanking BglII and
NdeI sites in nef. Conversely, the mutated region
in the 239nefMTPI
5 construct was replaced with the corresponding
239wt and nef* sequences to generate the 239nef+TPI
5 and
239nef*TPI
5 variants. SIVmac239 nef* contains a premature
in-frame TAA stop signal at the 93rd codon of nef (23). Three additional variants (239nefMTPI, 239nef+TPI,
and 239nef*TPI) were generated the same way except that the mutated nef alleles were inserted into the proviral 239
NU clone,
in which 65 bp upstream of the core enhancer elements are maintained
(17). The U3 deletions were present in both LTRs to
prevent recombination. All PCR-derived inserts were sequenced to
confirmed that only the intended changes were present.

View larger version (20K):
[in this window]
[in a new window]
|
FIG. 1.
Schematic representation of modifications introduced
into the SIVmac239 genome to eliminate the nef-LTR
overlap. The 239wt clone (top) contains a 517-bp U3 region that
overlaps the 792-bp nef ORF by 407 bp (79%)
(34). The TPI region in nef was mutated,
and an intact TPI element was inserted upstream of the single NF- B
site. Furthermore, 384 bp of upstream U3 sequences were deleted from
the 5' LTR to prevent recombination with the modified 3' LTR region.
The nefMTPI 5 provirus (bottom) contains a U3 region of 133 bp and a
nef gene that neither overlaps the 3' LTR nor contains
essential cis-regulatory elements. The black bar
indicates the position of the deletion, and the arrows indicate the
positions of the mutated and functional TPI regions. Abbreviations: x,
vpx; r, vpr.
|
|

View larger version (24K):
[in this window]
[in a new window]
|
FIG. 2.
Mutant construction and SIVmac239 nef-LTR
variants analyzed. (A) The US384 construct, which contains a
deletion of 182 bp in the nef unique region and 384 bp
in the U3 region (33), was used to generate nefMTPI 5.
As indicated below, a PCR restriction fragment containing 13 silent
point mutations in the TPI region was cloned into US384 to generate
nefMTPI 5. (B) Schematic presentation of the SIVmac constructs
analyzed (left) and the deduced 5' LTR promoter region (right). TPImut
differs from 239wt only by the specific point mutations in the TPI
region; nef+TPI and nef+TPI 5 contain wild-type nef
genes; nefMTPI and nefMTPI 5 contain TPI-mutated nef
alleles. Otherwise isogenic forms with a premature stop signal at the
93rd codon of the nef ORF were also generated. The
TPI 5 forms contain 14 bp and the TPI forms contain 65 bp of US
sequences. Abbreviations: E-CP, enhancer-core promoter; Int,
U3-terminal sequences required for integration.
|
|
Virus stocks, cells, and infectivity assays.
For virus
production, 293T cells were transfected by the calcium phosphate
method, and virus production was quantitated as described previously
(4, 5). 293T, CEMx174 cells, the herpesvirus saimiri-transformed T-cell line 221 (1), and rhesus
peripheral blood mononuclear cells (rPBMC) were isolated and cultured
as described previously (4, 5). The cells were infected,
and virus replication was measured by reverse transcriptase assay as
described (5). SIVmac infectivity was determined using
sMAGI cells as described previously (7) and quantitated
using the Galacto-Light Plus chemiluminescence reporter assay kit
(Tropix, Bedford, Mass.), as recommended by the manufacturer.
Animal studies.
Three juvenile rhesus macaques of Indian
origin were infected by intravenous inoculation of SIVmac239nefMTPI
5
containing 5 ng of p27 produced by transfected 293T cells. The animals
were healthy and seronegative for SIV, type D retroviruses, and simian T-cell lymphotropic virus type 1 at the time of infection. Blood was
collected at regular intervals, and serological, virological, and
immunological analysis was performed as described previously (5,
28, 38).
PCR analysis.
SIV sequences spanning the entire
nef-U3 region were amplified from rPBMC DNA with a nested
PCR approach or from DNA isolated from positive PBMC-CEMx174 bulk
cocultivation or infected CEMx174 cells by one round of amplification
essentially as described (5, 28). Viral plasma RNA was
isolated with the QIAamp RNA kit (Diagen, Basel, Switzerland), reverse
transcribed with Superscript RT (Gibco-BRL, Eggenstein, Germany), and
subjected to a standard nested PCR approach. PCR fragments were
sequenced directly or following subcloning into the pCRII vector
(Invitrogen Corp., San Diego, Calif.). Sequencing was performed as
described previously (28). The following primers were used
to analyze the proviral LTR sequences: pP1
(5'-GATCCAACTCTGGCCTACAC-3'; 260 to 278 and 9722 to 9741);
pP2 (5'-CCGTCGTGGTTGGTTCCTGCC-3'; 891 to 912); pP3
(5'-TCGCTGAAACAGCAGGGACT-3; 400 to 420 and 9862 to 9882);
and pP4 (5'-GATTTTCCTGCTTCGGTTTCCC-3'; 790 to 808 and 10252 to 10270). Numbers refer to positions in the proviral SIVmac 239wt
sequence (34).
Western blot analysis.
CEMx174 cells were infected with
virus containing 10 ng of p27 core antigen derived from transfected 293 T cells. When cytopathic effects were observed, cells were pelleted,
and lysates were generated as described previously (5).
Expression of Nef proteins in whole cellular lysates was analyzed by
immunoblot using a rabbit anti-Nef serum (13). For
detection of p27 core protein, an anti-Gag monoclonal antibody derived
from SIVmac p27 hybridoma cells (55-2F12) was used (18).
For enhanced chemiluminescent detection, horseradish peroxidase-conjugated secondary antibodies were used as described by
the manufacturer of the ECL detection system (Amersham, Chicago, Ill.).
 |
RESULTS |
Construction of SIV TPI mutants.
The 792-bp SIVmac239
nef ORF overlaps about 80% (407 bp) of the 517-bp U3 region
of the LTR and contains several essential cis-acting
elements (named the TPI region in this study): a T-rich region (bp 363 to 368); the polypurine tract (bp 369 to 383); and sequences required
for integration (bp 389 to 397) (numbers refer to the positions in the
239wt nef ORF). The TPI region in nef was
inactivated, and intact cis-regulatory elements were
inserted upstream of the single NF-
B site in the U3 region of the
SIVmac239 LTR to eliminate the nef-LTR overlap (Fig. 1). A
total of 13 point mutations were introduced to render the TPI region
dysfunctional (Fig. 2A). These nucleotide substitutions did not alter
the predicted Nef amino acid sequence. The following SIVmac239 variants
were generated: (i) 239-TPImut is isogenic to 239wt except for the specific changes in the TPI region shown in Fig. 2A; (ii) 239-nef+TPI contains an insertion encompassing the TPI region and 65 bp of upstream
U3 sequences, downstream of the nef gene; (iii) in
239-nefMTPI, the TPI region in the nef ORF of 239-nef+TPI is
mutated; (iv) 239-nef+TPI
5 contains an insertion encompassing the
TPI region just downstream of the nef gene and 14 bp
upstream of the NF-
B binding site; and (v) in 239-nefMTPI
5, the
TPI region in the nef ORF of 239-nef+TPI
5 is mutated
(Fig. 2B). The right panel of Fig. 2B shows the 5' LTR regions
predicted after RT. The TPImut mutant is predicted to be inactive
because it lacks sequences required for RT and integration. In
contrast, the SIVmac239 nef+TPI and nef+TPI
5 variants contain two
copies of these cis-regulatory elements. Therefore, RT and
integration can result in two different forms of the proviral 5' LTR.
In comparison, the nefMTPI and nefMTPI
5 proviruses are predicted to
contain only short U3 regions at the 5' end of the genome. In addition
to the mutants shown in Fig. 2B, nef-defective variants of
the 239-nefMTPI and 239-nefMTPI
5 clones, containing a stop signal at
the 93rd codon of the nef ORF, were also generated
(239-nef*TPI and 239-nef*TPI
5, respectively).
SIV variants containing TPI elements downstream of
nef are replication competent and express functional
Nef.
CEMx174 cells were infected with virus stocks derived from
transiently transfected 293T cells to investigate the replicative potential of the SIVmac TPI variants. No RT activities above background levels were measured after infection with the control 239-TPImut virus
(Fig. 3A). This variant, which does not
contain intact TPI sequences at the 3' end of the proviral genome, also
did not replicate when very high doses of virus (up to 100 ng of p27
antigen) were used for infection (data not shown). In agreement with
previous studies (24, 28), SIVmac 239wt and 239nef*
replicated with comparable efficiency in CEMx174 cells. With the
exception of 239-TPImut, all other SIVmac239 TPI variants replicated
only slightly less efficiently than the parental 239wt clone (Fig. 3A).
Thus, the presence of an additional TPI region or truncation of US
sequences did not impair SIVmac replication in CEMx174 cells. PCR
amplification and sequence analysis of nef-LTR and
LTR-gag sequences at the end of culture demonstrated that
all proviral sequences contained the predicted U3 sequences at the 5'
end of the viral genome (Fig. 2B) and showed that no reversions in the
mutated nef alleles were selected during in vitro culture
(data not shown). Western blot analysis revealed that SIVmac forms
containing the 239wt or the TPI-mutated nef genes, but not
the nef* variants, expressed the Nef protein (Fig. 3B and data not
shown).

View larger version (33K):
[in this window]
[in a new window]
|
FIG. 3.
SIVmac239 TPI variants are replication competent and
express Nef. (A) Replication of SIVmac239 variants in CEMx174 cells.
Virus containing 10 ng of p27 was used for infection. RT activity was
determined using a phosphorimager. PSL, photon-stimulated light
emission. (B) Nef and p27 antigen expression in infected CEMx174 cells
was verified by immunoblot using rabbit anti-Nef antiserum or a
monoclonal anti-p27 antibody as described previously (5).
Similar results were obtained in two independent experiments.
|
|
Next, we investigated if the TPI-mutated
nef alleles are
able to enhance SIVmac infectivity. As shown in Fig.
4, SIVmac 239wt
infected sMAGI with about
eightfold higher efficiency than the
nef-defective 239nef*
variant. Insertion of TPI-US65 (nef+TPI)
or the TPI region
(nef+TPI

5) downstream of the
nef ORF did not
reduce viral
infectivity. Mutation of the TPI sequences in
nef in the
presence of a second downstream TPI region (nefMTPI and
nefMTPI

5)
resulted in slightly enhanced infectivity compared
to the corresponding
constructs with duplicated TPI regions (nef+TPI
and nef+TPI

5). A
premature stop codon reduced the infectivity
of the nefMTPI and
nefMTPI

5 variants to a level comparable to
that of 239nef* (see
nef*TPI and nef*TPI

5, Fig.
4). These results
show that the
TPI-mutated
nef alleles are functional in enhancing
viral
infectivity.

View larger version (36K):
[in this window]
[in a new window]
|
FIG. 4.
SIV nef alleles containing changes in the
TPI region enhance viral infectivity and replication. sMAGI cells were
infected with the indicated SIVmac239 TPI-nef variants
containing 50 ng of p27 antigen. Infections were performed in
triplicate with three different virus stocks.
|
|
It has been shown previously that a functional
nef gene
enhances SIVmac replication in the rhesus macaque T-lymphoid cell
line
221, particularly in the absence of interleukin-2 (IL-2)
(
1). We investigated the replicative capacity of the
SIVmac
TPI variants in 221 cells to clarify if the mutated
nef alleles
are able to cause lymphoid cell activation. With
the exception
of the TPImut form, all variants replicated in 221 cells
in the
presence of IL-2 (Fig.
5A).
However, intact
nef genes resulted
in faster growth kinetics
and increased replication relative to
the forms containing disrupted
nef genes. In the absence of IL-2,
only forms containing
wild-type or TPI-mutated
nef alleles showed
marked levels of
replication (Fig.
5B). The nef+TPI

5 and nefMTPI

5
variants, in
which essentially the entire U3 region between the
sequences required
for integration and the core enhancer elements
are deleted, were more
active than the forms containing the 65
bp upstream of the NF-

B
binding sites (Fig.
5). Thus, the TPI-mutated
nef alleles
stimulated SIVmac replication with an efficiency comparable
to that of
239wt
nef, and short U3 regions accelerated rather
than
reduced viral replication in 221 cells. In agreement with
the results
obtained using 221 cells, the 239nef+TPI, 239nefMTPI,
239nef+TPI

5,
and 239nefMTPI

5 variants replicated efficiently
in rPBMC which were
infected immediately after isolation and stimulated
with
phytohemagglutinin (PHA) 3 days later (Fig.
6A). The
nef-defective
SIVmac
variants 239nef*, 239

NU, 239

US384, 239nef*TPI, and 239nef*TPI

5
were inactive under these experimental conditions. In comparison,
only
the TPImut variant did not show appreciable levels of replication
in
stimulated PBMC, although the forms expressing functional Nef
showed a
higher replicative capacity than the nef* or
nef-deleted
forms (Fig.
6B).

View larger version (24K):
[in this window]
[in a new window]
|
FIG. 5.
SIVmac239 variants without overlapping
nef-U3 sequences express functional Nef and replicate
efficiently in 221 cells. Replication in of the indicated 239 mutants
in 221 cells was tested in the presence (A) and absence (B) of IL-2.
Similar results were obtained in two independent experiments using
different virus stocks.
|
|

View larger version (22K):
[in this window]
[in a new window]
|
FIG. 6.
Replication of SIVmac TPI-nef variants in
rPBMC. (A) Unstimulated rPBMC were infected immediately after isolation
and stimulated with PHA 3 days postinfection. (B) rPBMC were PHA
stimulated for 3 days prior to infection. The results shown were
derived from a single experiment using rPBMC derived from the same
animal. Similar results were obtained with rPBMC from two different
rhesus macaques.
|
|
These results demonstrate that the TPI-mutated
nef alleles
are expressed in infected cells and enhance SIVmac infectivity
and
replication with an efficiency comparable to that of the 239wt
nef allele. In agreement with previous studies (
21,
26,
33),
the U3 region upstream of the core enhancer element was
dispensable
for efficient viral
replication.
Amino acid residues encoded by TPI region are important for Nef
function.
One rationale for the construction of the SIVmac TPI
mutants was to establish a system that allows investigation of Nef
function without the complications of essential overlapping
cis-regulatory sequences. We introduced mutations in the
nef gene of the nefMTPI
5 variant, predicting changes of
two lysines,
K124/K127
A124/A127 (MTPI-KK-AA), and two tyrosine residues,
Y133/Y134
F133/F134
(MTPI-YY-FF). Some of the nucleotide substitutions are present at
positions corresponding to important cis-regulatory
elements, like the polypurine tract in 239wt (Fig. 2A). Changes in both
the lysine and tyrosine residues reduced the ability of SIV-Nef to
increase virion infectivity for sMAGI cells (Fig.
7A). Furthermore, the mutated
nef alleles did not stimulate SIVmac replication in PBMC
culture (Fig. 7B). Our results demonstrate that these amino acid
residues in Nef are not only highly conserved, because they are encoded
by essential cis-regulatory RNA elements, but are also
important for Nef function.

View larger version (19K):
[in this window]
[in a new window]
|
FIG. 7.
cis-Regulatory elements in
nef encode amino acids residues important for Nef
function. (A) sMAGI cells were infected in triplicate with 293T
cell-derived virus stocks containing 50 ng of p27. Infectivity is shown
relative to that of 239wt virus. (B) rPBMC were infected immediately
after isolation and stimulated with PHA at day 3 postinfection. Similar
results were obtained in an independent experiment.
|
|
SIVmac239 nefMTPI
5 variant replicates efficiently in rhesus
macaques.
Three rhesus macaques were experimentally infected with
the nefMTPI
5 variant to investigate whether SIVmac variants without overlapping nef-LTR sequences and with short U3 LTR
sequences replicate efficiently in vivo. The nefMTPI
5 mutant was
selected for in vivo analysis because it contained the shortest U3
region (133 bp) in conjunction with an intact nef gene and
showed a phenotype similar to that of 239wt in in vitro infectivity and
replication assays. The replicative capacity of the nefMTPI
5 mutant
was compared with that of 239wt and
NU, which have been extensively
analyzed in vivo (5, 17, 24). As shown in Fig.
8A, the p27 levels observed during the
acute phase of infection by nefMTPI
5 (1,721 ± 1,017 pg/ml)
were only 2-fold lower than those observed for 239wt infection
(3,428 ± 2,648 pg/ml, n = 15) and about 25-fold higher than those observed in animals infected with the
nef-deleted SIVmac
NU variant (67 ± 39 pg/ml,
n = 4). In agreement with the high levels of plasma
viremia, the levels of viral RNA (7.1 × 106 ± 6.2 × 106 copies/ml)
were also more similar to infection with pathogenic nef-open
forms of SIVmac239 (1.1 × 107 ± 7.5 × 106, n = 11), than to
NU
infection (1.8 × 105 ± 1.2 × 105, n = 4) (Fig. 8B). The
initial peak levels (days 11 to 15) of urinary neopterin, a marker of
immune activation, were high (15.9 [± 2.0] times baseline), even
compared to those measured in 239wt-infected animals (10.5 ± 3.1, n = 10) (Fig. 8C). All three animals that received the
nefMTPI
5 variant became chronically infected and maintained high
cell-associated viral loads throughout the course of infection,
comparable to 239wt-infected macaques (Fig.
9A). Similarly, in monkeys Mm10032
and Mm10033, the RNA levels were comparable to those observed in 239wt
infection (Fig. 9B). The remaining animal, Mm10034, showed RNA loads
intermediate between those after 239wt and
NU infection. All animals
showed a marked reduction in CD4+ cells during
acute infection, which was most apparent for the CD4+ CD29+ memory T-cell
subset (day 0, 199 ± 65/µl; 2 weeks postinfection [wpi],
101± 19/µl; 4 wpi, 35 ± 48/µl). Mm10032 and Mm10033 showed partial recovery and maintained relatively stable
CD4+ cell counts (
500/µl at 44 and 52 weeks
of follow-up, respectively). The overall CD4+
T-cell count measured during chronic infection corresponded to about
50% of the preinfection values. Similarly, the number of CD4+ CD29+ cells remained
at about 40% of the preinfection value (data not shown). Unexpectedly,
Mm10034, which developed the lowest viral load (Fig. 9), had the
greatest reduction in the number of circulating CD4+ T cells. The absolute number of
CD4+ T cells dropped from 580/µl to 32/µl,
and the CD4+ CD29+ cell
count fell from 108/µl to 5/µl by 4 wpi. Thereafter, the CD4+ T-cell count of Mm10034 partially recovered
(164/µl by 52 wpi), whereas the number of CD4+
CD29+ cells remained very low (<10/µl; data
not shown). One animal, Mm10032, had to be euthanized at 44 wpi because
of severe diarrhea. Hemolytic Escherichia coli,
Klebsiella sp., Giardia sp., and Entamoeba sp. were isolated from the intestine, indicating a severe
immunodeficiency associated with opportunistic infections. The
remaining two animals are still alive 1 year postinfection. However,
all animals infected with the nefMTPI
5 variant exhibited signs of
immunodeficiency, indicated by either CD4+ cell
loss or overt AIDS-like symptoms. The levels of replication and
characteristics of infection were similar to those observed in
nef-open SIVmac239 infection.

View larger version (14K):
[in this window]
[in a new window]
|
FIG. 8.
nefMTPI 5 variant behaves similar to 239wt in acutely
infected rhesus macaques. Maximum levels of p27 plasma antigenemia (A),
viral RNA (B), and urinary neopterin (C) in three animals infected with
the nefMTPI 5 variant. For comparison, values obtained from macaques
infected with NU or 239wt are also indicated. Peak levels of p27
plasma antigenemia and of viral RNA were always observed at 2 wpi. The
neopterin/creatinine ratio is expressed for each animal as the
fold increase over the mean ratios determined prior to infection as
described previously (20).
|
|

View larger version (23K):
[in this window]
[in a new window]
|
FIG. 9.
Replication of SIVmac239 nefMTPI 5 variant in vivo.
(A) Number of infectious cells per 106 PBMC. (B) Viral RNA
load. The detection limit for viral RNA is approximately 40 copies/ml
(38). For comparison, curves for the average values
obtained from rhesus macaques infected with 239wt and NU are
indicated. Standard deviations are not shown for clarity. Parameters
were determined as described in Materials and Methods.
|
|
HIV and SIV are highly variable and point mutations in
nef
that attenuate viral replication can revert rapidly in vivo
(
24).
Therefore, we investigated whether changes in the
mutated
nef-LTR
region were selected in the animals infected
with the nefMTPI

5
mutant. Sequence analysis of
nef-LTR
PCR fragments amplified directly
from plasma RNA, PBMC, or
virus-positive bulk cocultures revealed
that no reversions in the
mutated TPI region in the
nef gene were
detectable after 40 weeks of follow-up (data not shown). Furthermore,
the TPI region
downstream of
nef and upstream of the NF-

B site
was
always maintained. We found that the TPImut variant did not
show
significant levels of replication (Fig.
5 and
6), suggesting
that the
mutated elements were nonfunctional. Next, we performed
PCR analysis of
nef-LTR sequences of virus reisolated from animals
infected
with SIVmac239 nefMTPI

5 to further confirm that the
mutated TPI
region was not used for reverse transcription and
integration and that
function was not restored in infected macaques.
Amplification with
primers pP1 and pP2, which bind to the US region
and the noncoding
region flanking the 5' LTR, yielded a 632-bp
fragment from DNA prepared
from positive bulk cocultures derived
from 239wt-infected animals (Fig.
10, lane 6, and data not shown).
In
contrast, no specific product was obtained with virus reisolated
from
the three animals infected with the nefMTPI

5 mutant (Fig.
10, lanes
3 to 5). This result confirms that the U3 region of the
5' LTR is
truncated and does not contain the binding site for
primer pP1. In
comparison, PCRs performed with primers p1 and
p4 yielded products for
both 239wt- and nefMTPI

5-infected animals
(Fig.
10, lanes 9 to 12).
The fragments obtained for the mutant
form were larger than the
products obtained for 239wt. This was
expected because these primers
span the region at the 3' end of
the viral genome that contains the
inserted TPI region in the
nefMTPI

5 genome (Fig.
10, upper panel).
Finally, PCRs with primers
pP3 and pP2, which bind to the 3' end of the
U3 region, which
is maintained at the 5' LTR of both the 239wt and the
nefMTPI

5
proviruses, yielded products of 513 bp for DNA from all
bulk cocultures
(Fig.
10, lanes 15 to 18). Thus, the results of both
the sequence
and PCR analyses consistently show that the mutations in
the
nef-LTR
region of nefMTPI

5 did not revert in infected
animals and that
the mutant virus maintained a truncated U3 region.

View larger version (54K):
[in this window]
[in a new window]
|
FIG. 10.
Analysis of nef-LTR sequences derived
from nefMTPI 5-infected rhesus monkeys. (A) Schematic representation
of the predicted 5' and 3' ends of the 239wt and nefMTPI 5
proviruses. Arrows indicate the positions of primers used for PCR
amplification. The abbreviations are described in the legend to Fig. 2.
(B) SIV LTR and nef-LTR sequences were amplified from
positive PBMC-CEMx174 bulk cocultures. PBMC were derived at 40 wpi from
three macaques infected with nefMTPI 5 (Mm10032, Mm10033, and
Mm10034) and one animal that received 239wt (Mm10027). PCR products
were separated by electrophoresis through 1.5% agarose gels.
|
|
 |
DISCUSSION |
We designed SIVmac239 mutants containing an intact nef
gene which does not overlap the U3 region of the LTR and does not
include essential cis-regulatory elements. The TPI-mutated
nef alleles were functional in enhancing SIVmac infectivity
and replication. Elimination of the U3 sequences upstream of the core
enhancer elements had little if any effect on replicative capacity in
cell culture or in rhesus macaques. Our observation that the upstream U3 sequences of SIVmac serve primarily or exclusively as nef
coding sequence is consistent with previous studies. It has been shown that the US region is selectively deleted in vivo in the absence of an
intact nef gene (26) and can be mutagenized
extensively without loss of virulence (21).
We generated two sets of SIVmac239 TPI variants. One contained a U3
region of 183 bp, in which 65 bp of US sequences were maintained, and
the other contained a U3 region of only 117 bp, in which essentially
all US sequences are deleted. The 65 bp upstream of the single NF-
B
binding site were always preserved in macaques infected with
nef-deleted SIVmac239 (26) and were not altered in a previous study on the functional role of the US region
(21). This region of the SIVmac LTR contains binding sites
for Ets family transcription factors, which allow efficient viral
replication in the absence of the entire core enhancer element
(33). We found that the nefMTPI
5 variant, which does
not contain the US65 region, was more active in infectivity and
replication assays than the nefMTPI variant. Our results extend
previous studies (21, 26, 33) and demonstrate that the 3'
end of the U3 region, encompassing the NF-
B and Sp1 binding sites
and the TATA box is sufficient for efficient replication of SIVmac both
in vitro and in vivo in rhesus macaques. It remains to be clarified why the genome of primate lentiviruses is always organized so that the
nef gene overlaps the 3' LTR. Certainly we cannot exclude that this genomic organization has some subtle advantage in certain cell types or tissues. Indeed, although the characteristics of infection with the nefMTPI
5 variant were much more similar to those
of 239wt than to those of 239
nef, it seemed that this
mutant virus was relatively well controlled by the antiviral immune
responses. Studies in large numbers of infected animals would be
required to clarify if these minor differences are significant. A
number of factors could explain how the TPI mutations affect viral
replication in infected macaques. Nef expression levels might be
slightly reduced, the mutations could affect the stability of the viral RNA, or the US sequences might have some effect on transcriptional activity in primary cells. However, the wild-type-like phenotype of the
mutant virus in vivo and in vitro and the lack of reversions in
infected macaques indicate that these attenuating effects may be very subtle.
Previous results on the functional relevance of the upstream U3 region
were derived from infections with nef-deleted viruses (26, 27) or from SIVmac mutants that still contained the
overlap of the nef gene and the LTR (21). In
contrast, the nefMTPI
5 variant contains an intact nef
gene that neither overlaps the LTR nor contains any essential
cis-regulatory elements. We demonstrate that the TPI-mutated
nef allele increases SIVmac infectivity and replication with
an efficiency indistinguishable from that of 239wt nef.
Usually, about 60% of the nef gene is overlapped by the U3
region of the LTR or by important cis-regulatory elements. Detailed structure-function analysis of Nef is complicated because mutations in the central region or the 3' half of the nef
gene not only might alter Nef function but also could have unexpected effects on transcriptional activity, integration, or RT. The constructs generated in the present study extend the experimental possibilities for the analysis of nef function in infected cells. Such
systems are obligatory to study the effect of Nef on viral replication and pathogenesis. However, it remains important to investigate other
nef functions in primary infected cells because (i) effects of Nef on cellular signal transduction or activation are often not
observed in immortalized tumor cell lines, (ii) cellular kinases or
other factors might only be expressed in relevant primary cells and
binding to Nef might be affected by the presence of other viral
proteins, (iii) the influence of Nef on the cell surface expression of
various molecules might depend on the coexpression of other viral
factors, e.g., both Vpu and Env also reduce CD4 surface expression
levels (10, 40), and (iv) essentially all activities of
Nef strongly depend on protein expression levels. Thus, overexpression
of Nef by expression constructs in transfected cells may generate
misleading data. The constructs generated in this study should be
useful for delineating the molecular mechanisms that underlie the
various Nef functions and investigating their relevance to viral
replication in vivo. We show that lysine and tyrosine residues, which
are encoded by important cis-regulatory elements in the
239wt nef ORF, are important for the ability of Nef to
increase infectivity and replication. Our results suggest that this
region in the nef gene is highly conserved not only because
it contains important regulatory elements, but also because it encodes
residues that are important for Nef function.
We demonstrate that the conserved genomic organization of the 3' end of
the genome of primate lentiviruses, specifically the large overlap
between the nef gene and the LTR, is not obligatory for
efficient replication of SIVmac. We are currently investigating if
analogous HIV-1 TPI variants can be generated. Our initial focus was on
SIV rather than on HIV-1 in this study because SIVmac239 allows studies
of viral pathogenicity in a well-characterized animal model. Pathogenic
HIV-SIV hybrid Nefs have recently been described (2, 25).
However, the current forms are of limited value for pathogenesis
studies because they only induced disease in a subset of infected
macaques. The SIV constructs described in this work should prove useful
for the detailed structure-function analysis of Nef in infected cells.
 |
ACKNOWLEDGMENTS |
We thank Bernhard Fleckenstein for support and encouragement,
Mandy Krumbiegel for excellent technical assistance, and Julie Overbaugh and Bryce Chackerian for sMAGI cells.
This work was supported by the Wilhelm-Sander Foundation, BMBF grant
01Ki9478, and the Deutsche Forschungsgesellschaft.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Abteilung
Virologie, Institut für Mikrobiologie und Immunologie,
Unversitätsklinikum Ulm, Ulm, Germany. Phone: 49-731-5002 3344. Fax: 49-731-5002 3389. E-mail:
frank.kirchhoff{at}medizin.uni-ulm.de.
Present address: Abteilung Virologie, Institut für
Mikrobiologie und Immunologie, Unversitätsklinikum Ulm, Ulm, Germany.
 |
REFERENCES |
| 1.
|
Alexander, L.,
Z. Du,
M. Rosenzweig,
J. J. Jung, and R. C. Desrosiers.
1997.
A role for natural SIV and HIV-1 nef alleles in lymphocyte activation.
J. Virol.
71:6094-6099[Abstract].
|
| 2.
|
Alexander, L.,
Z. Du,
A. Y. Howe,
S. Czajak, and R. C. Desrosiers.
1999.
Induction of AIDS in rhesus monkeys by a recombinant simian immunodeficiency virus expressing nef of human immunodeficiency virus type 1.
J. Virol.
73:5814-5825[Abstract/Free Full Text].
|
| 3.
|
Benson, R. E.,
A. Sanfridson,
J. S. Ottinger,
C. Doyle, and B. R. Cullen.
1993.
Downregulation of cell-surface CD4 expression by simian immunodeficiency virus Nef prevents viral super infection.
J. Exp. Med.
177:1561-1566[Abstract/Free Full Text].
|
| 4.
|
Carl, S.,
A. J. Iafrate,
C. Stahl-Hennig,
J. Skowronski, and F. Kirchhoff.
1999.
Effect of the attenuating deletion and of sequence alterations evolving in vivo on simian immunodeficiency virus C8-Nef function.
J. Virol.
73:2790-2797[Abstract/Free Full Text].
|
| 5.
|
Carl, S.,
A. J. Iafrate,
S. M. Lang,
N. Stolte,
K. Matz-Rensing,
D. Fuchs,
C. Stahl-Hennig,
J. Skowronski, and F. Kirchhoff.
2000.
Simian immunodeficiency virus containing mutations in N-terminal tyrosine residues and in the PxxP motif in Nef replicates efficiently in rhesus macaques.
J. Virol.
74:4155-4164[Abstract/Free Full Text].
|
| 6.
|
Carl, S.,
T. C. Greenough,
M. Krumbiegel,
M. Greenberg,
J. Skowronski,
J. L. Sullivan, and F. Kirchhoff.
2001.
Modulation of different human immunodeficiency virus type 1 Nef functions during progression to AIDS.
J. Virol.
75:3657-3665[Abstract/Free Full Text].
|
| 7.
|
Chackerian, B.,
N. L. Haigwood, and J. Overbaugh.
1995.
Characterization of a CD4-expressing macaque cell line that can detect virus after a single replication cycle and can be infected by diverse simian immunodeficiency virus isolates.
Virology
213:386-394[CrossRef][Medline].
|
| 8.
|
Chowers, M. Y.,
C. A. Spina,
T. J. Kwoh,
N. J. Fitch,
D. D. Richman, and J. C. Guatelli.
1994.
Optimal infectivity in vitro of human immunodeficiency virus type 1 requires an intact nef gene.
J. Virol.
68:2906-2914[Abstract/Free Full Text].
|
| 9.
|
Collins, K. L.,
B. K. Chen,
S. A. Kalams,
B. D. Walker, and D. Baltimore.
1998.
HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes.
Nature
391:397-401[CrossRef][Medline].
|
| 10.
|
Crise, B.,
L. Buonocore, and J. K. Rose.
1990.
CD4 is retained in the endoplasmic reticulum by the human immunodeficiency virus type 1 glycoprotein precursor.
J. Virol.
64:5585-5593[Abstract/Free Full Text].
|
| 11.
|
Deacon, N. J.,
A. Tsykin,
A. Solomon,
K. Smith,
M. Ludford-Menting,
D. J. Hooker,
D. A. McPhee,
A. L. Greenway,
A. Ellett, and C. Chatfield.
1995.
Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients.
Science
270:988-991[Abstract/Free Full Text].
|
| 12.
|
deRonde, A.,
B. Klaver,
W. Keulen,
L. Smit, and J. Goudsmit.
1992.
Natural HIV-1 NEF accelerates virus replication in primary human lymphocytes.
Virology
188:391-395[CrossRef][Medline].
|
| 13.
|
Du, Z.,
S. M. Lang,
V. G. Sasseville,
A. A. Lackner,
P. O. Ilyinskii,
M. D. Daniel,
J. U. Jung, and R. C. Desrosiers.
1995.
Identification of a nef allele that causes lymphocyte activation and acute disease in macaque monkeys.
Cell
82:665-674[CrossRef][Medline].
|
| 14.
|
Emerman, M., and M. H. Malim.
1998.
HIV-1 regulatory/accessory genes: keys to unraveling viral and host cell biology.
Science
280:1880-1884[Abstract/Free Full Text].
|
| 15.
|
Garcia, J. V., and A. D. Miller.
1991.
Serine phosphorylation-independent downregulation of cell-surface CD4 by nef.
Nature
350:508-511[CrossRef][Medline].
|
| 16.
|
Glushakova, S.,
J. C. Grivel,
K. Suryanarayana,
P. Meylan,
J. D. Lifson,
R. C. Desrosiers, and L. Margolis.
1999.
Nef enhances human immunodeficiency virus replication and responsiveness to interleukin-2 in human lymphoid tissue ex vivo.
J. Virol.
73:3968-3974[Abstract/Free Full Text].
|
| 17.
|
Gundlach, B. R.,
H. Linhart,
U. Dittmer,
S. Sopper,
S. Reiprich,
D. Fuchs,
B. Fleckenstein,
G. Hunsmann,
C. Stahl-Hennig, and K. Überla.
1997.
Construction, replication, and immunogenic properties of a simian immunodeficiency virus expressing interleukin 2.
J. Virol.
71:2225-2232[Abstract].
|
| 18.
|
Higgins, J. R.,
S. Sutjipto,
P. A. Marx, and N. C. Pedersen.
1992.
Shared antigenic epitopes of the major core proteins of human and simian immunodeficiency virus isolates.
J. Med. Primatol.
21:265-269[Medline].
|
| 19.
|
Iafrate, A. J.,
S. Bronson, and J. Skowronski.
1997.
Separable functions of Nef disrupt two aspects of T cell receptor machinery: CD4 expression and CD3 signaling.
EMBO J.
16:673-684[CrossRef][Medline].
|
| 20.
|
Iafrate, A. J.,
S. Carl,
S. Bronson,
C. Stahl-Hennig,
T. Swigut,
J. Skowronski, and F. Kirchhoff.
2000.
Disrupting surfaces of Nef required for downregulation of CD4 and for enhancement of virion infectivity attenuates simian immunodeficiency virus replication in vivo.
J. Virol
74:9836-9844[Abstract/Free Full Text].
|
| 21.
|
Ilyinskii, P. O.,
M. D. Daniel,
M. A. Simon,
A. A. Lackner, and R. C. Desrosiers.
1994.
The role of upstream U3 sequences in the pathogenesis of simian immunodeficiency virus-induced AIDS in rhesus monkeys.
J. Virol.
68:5933-5944[Abstract/Free Full Text].
|
| 22.
|
Ilyinskii, P. O., and R. C. Desrosiers.
1998.
Identification of a sequence element immediately upstream of the polypurine tract that is essential for replication of simian immunodeficiency virus.
EMBO J.
17:3766-3774[CrossRef][Medline].
|
| 23.
|
Kestler, H. W.,
T. Kodama,
D. J. Ringler,
M. Marthas,
N. Pedersen,
A. Lackner,
D. Regier,
P. K. Sehgal,
M. D. Daniel, and R. C. Desrosiers.
1990.
Induction of AIDS in rhesus monkeys by molecularly cloned simian immunodeficiency virus.
Science
248:1109-1112[Abstract/Free Full Text].
|
| 24.
|
Kestler, H. W.,
D. J. Ringler,
K. Mori,
D. L. Panicali,
P. K. Sehgal,
M. D. Daniel, and R. C. Desrosiers.
1991.
Importance of the nef gene for maintenance of high virus loads and for development of AIDS.
Cell
65:651-662[CrossRef][Medline].
|
| 25.
|
Kirchhoff, F.,
J. Münch,
S. Carl,
N. Stolte,
K. Mätz-Rensing,
D. Fuchs,
P. Ten Haaft,
J. L. Heeney,
T. Swigut,
J. Skowronski, and C. Stahl-Hennig.
1999.
The human immunodeficiency virus type 1 nef gene can to a large extent replace simian immunodeficiency virus nef in vivo.
J. Virol.
73:8371-8383[Abstract/Free Full Text].
|
| 26.
|
Kirchhoff, F.,
H. W. Kestler, and R. C. Desrosiers.
1994.
Upstream U3 sequences in simian immunodeficiency virus are selectively deleted in vivo in the absence of an intact nef gene.
J. Virol.
68:2031-2037[Abstract/Free Full Text].
|
| 27.
|
Kirchhoff, F.,
T. C. Greenough,
D. B. Brettler,
J. L. Sullivan, and R. C. Desrosiers.
1995.
Absence of intact nef sequences in a long-term, nonprogressing survivor of HIV-1 infection.
N. Engl. J. Med.
332:228-232[Free Full Text].
|
| 28.
|
Lang, S. M.,
A. J. Iafrate,
C. Stahl-Hennig,
E. M. Kuhn,
T. Ni lein,
M. Haupt,
G. Hunsmann,
J. Skowronski, and F. Kirchhoff.
1997.
Association of simian immunodeficiency virus Nef with cellular serine/threonine kinases is dispensable for the development of AIDS in rhesus macaques.
Nat. Med.
3:860-865[CrossRef][Medline].
|
| 29.
|
Lock, M.,
M. E. Greenberg,
A. J. Iafrate,
T. Swigut,
J. Münch,
F. Kirchhoff,
N. Shohdy, and J. Skowronski.
1999.
Two elements target SIV Nef to the AP-2 clathrin adaptor complex, but only one is required for the induction of CD4 endocytosis.
EMBO J.
18:2722-2733[CrossRef][Medline].
|
| 30.
|
Mariani, R., and J. Skowronski.
1993.
CD4 down-regulation by nef alleles isolated from human immunodeficiency virus type 1-infected individuals.
Proc. Natl. Acad. Sci. USA
90:5549-5553[Abstract/Free Full Text].
|
| 31.
|
Miller, M. D.,
M. T. Warmerdam,
I. Gaston,
W. C. Greene, and M. B. Feinberg.
1994.
The human immunodeficiency virus-1 nef gene product: a positive factor for viral infection and replication in primary lymphocytes and macrophages.
J. Exp. Med.
179:101-114[Abstract/Free Full Text].
|
| 32.
|
Peter, F.
1998.
HIV nef: the mother of all evil?
Immunity
9:433-437[CrossRef][Medline].
|
| 33.
|
Pöhlmann, S.,
S. Flö ,
P. O. Ilyinskii,
T. Stamminger, and F. Kirchhoff.
1998.
Sequences just upstream of the simian immunodeficiency virus core enhancer allow efficient replication in the absence of NF- B and Sp1 binding elements.
J. Virol.
72:5589-5598[Abstract/Free Full Text].
|
| 34.
|
Regier, D. A., and R. C. Desrosiers.
1989.
The complete nucleotide sequence of a pathogenic molecular clone of SIV.
AIDS Res. Hum. Retrovir.
6:1221-1231.
|
| 35.
|
Schwartz, O.,
V. Marechal,
S. Le Gall,
F. Lemonnier, and J. M. Heard.
1996.
Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein.
Nat. Med.
2:338-342[CrossRef][Medline].
|
| 36.
|
Spina, C. A.,
T. J. Kwoh,
M. Y. Chowers,
J. C. Guatelli, and D. D. Richman.
1994.
The importance of nef in the induction of human immunodeficiency virus type 1 replication from primary quiescent CD4 lymphocytes.
J. Exp. Med.
179:115-123[Abstract/Free Full Text].
|
| 37.
|
Swigut, T.,
A. J. Iafrate,
J. Münch,
F. Kirchhoff, and J. Skowronski.
2000.
Simian and human immunodeficiency virus Nef proteins use different surfaces to downregulate class I major histocompatibility antigen expression.
J. Virol.
74:5691-5701[Abstract/Free Full Text].
|
| 38.
|
Ten Haaft, P.,
B. Verstrepen,
K. Überla,
B. Rosenwirth, and J. Heeney.
1998.
A pathogenic threshold of virus load defined in simian immunodeficiency virus- or simian-human immunodeficiency virus-infected macaques.
J. Virol.
72:10281-10285[Abstract/Free Full Text].
|
| 39.
|
Varmus, H.
1988.
Retroviruses.
Science
240:1427-1435[Abstract/Free Full Text].
|
| 40.
|
Willey, R. L.,
F. Maldarelli,
M. A. Martin, and K. Strebel.
1992.
Human immunodeficiency virus type 1 Vpu protein induces rapid degradation of CD4.
J. Virol.
66:7193-7200[Abstract/Free Full Text].
|
Journal of Virology, September 2001, p. 8137-8146, Vol. 75, No. 17
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.17.8137-8146.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Mori, K., Sugimoto, C., Ohgimoto, S., Nakayama, E. E., Shioda, T., Kusagawa, S., Takebe, Y., Kano, M., Matano, T., Yuasa, T., Kitaguchi, D., Miyazawa, M., Takahashi, Y., Yasunami, M., Kimura, A., Yamamoto, N., Suzuki, Y., Nagai, Y.
(2005). Influence of Glycosylation on the Efficacy of an Env-Based Vaccine against Simian Immunodeficiency Virus SIVmac239 in a Macaque AIDS Model. J. Virol.
79: 10386-10396
[Abstract]
[Full Text]
-
Miles, L. R., Agresta, B. E., Khan, M. B., Tang, S., Levin, J. G., Powell, M. D.
(2005). Effect of Polypurine Tract (PPT) Mutations on Human Immunodeficiency Virus Type 1 Replication: a Virus with a Completely Randomized PPT Retains Low Infectivity. J. Virol.
79: 6859-6867
[Abstract]
[Full Text]
-
Blancou, P., Chenciner, N., Fang, R. H. T., Monceaux, V., Cumont, M.-C., Guetard, D., Hurtrel, B., Wain-Hobson, S.
(2004). Simian Immunodeficiency Virus Promoter Exchange Results in a Highly Attenuated Strain That Protects against Uncloned Challenge Virus. J. Virol.
78: 1080-1092
[Abstract]
[Full Text]
-
Quinto, I., Puca, A., Greenhouse, J., Silvera, P., Yalley-Ogunro, J., Lewis, M. G., Palmieri, C., Trimboli, F., Byrum, R., Adelsberger, J., Venzon, D., Chen, X., Scala, G.
(2004). High Attenuation and Immunogenicity of a Simian Immunodeficiency Virus Expressing a Proteolysis-resistant Inhibitor of NF-{kappa}B. J. Biol. Chem.
279: 1720-1728
[Abstract]
[Full Text]